Registre d'evidència del mètode

Phase I Clinical Trial

A Phase I clinical trial is the first stage of human testing for a new drug, biologic, or intervention. Its primary objective is to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) rather than therapeutic efficacy. Small cohorts of participants — typically healthy volunteers or patients with advanced disease — receive sequentially increasing doses to identify the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) that define the boundary for subsequent trials.

Sources recorded, not reviewed

Registre font

Les citacions es copien textualment del registre font del mètode. No s'infereix cap verificació a nivell de reclam d'elles.

Phase I Clinical Trial (First-in-Human / Dose-Escalation Study)

Registre de mètode taxonòmic · process-pipeline / epidemiology

Obre el mètode complet

Reclamacions curades

Les reclamacions s'han persistit al registre de proves, cadascuna amb la seva pròpia avaluació.

Encara no hi ha reclamacions curades

Aquesta vista no inventa una avaluació de reclam quan el registre no en té cap.

Mètodes relacionats

Generat a partir del gràfic de mètodes i mostrat com a relacions suggerides per la màquina; no s'infereix cap reclamació d'evidència.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Same method familyDiagnostic Accuracy Study Designmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDose-Response Analysismachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase II clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.